These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3530455)

  • 1. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
    Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
    Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
    Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
    Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of acivicin in advanced metastatic breast cancer.
    Fleishman G; Yap HY; Murphy WK; Bodey G
    Cancer Treat Rep; 1983 Sep; 67(9):843-4. PubMed ID: 6883364
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
    Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
    Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
    Maroun JA; Maksymiuk A; Eisenhauer E; Stewart DJ; Young V; Pater J
    Cancer Treat Rep; 1986 Nov; 70(11):1327-8. PubMed ID: 3021326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Raney M; Logan T
    Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I study of acivicin in patients with advanced cancer.
    Sridhar KS; Ohnuma T; Chahinian AP; Holland JF
    Cancer Treat Rep; 1983; 67(7-8):701-3. PubMed ID: 6871885
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of acivicin in malignant mesothelioma.
    Falkson G; Vorobiof DA; Simson IW; Borden EC
    Cancer Treat Rep; 1987 May; 71(5):545-6. PubMed ID: 3567981
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
    Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; DiSaia PJ; Buchsbaum HJ
    Invest New Drugs; 1986; 4(1):49-52. PubMed ID: 3700040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I-II trial of acivicin in adult acute leukemia.
    Powell BL; Craig JB; Capizzi RL; Richards F
    Invest New Drugs; 1988 Apr; 6(1):41-4. PubMed ID: 3165971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny NE; Gralla RJ
    Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II evaluation of pyrazofurin in patients with metastatic sarcoma.
    Gralla RJ; Sordillo PP; Magill GB
    Cancer Treat Rep; 1978 Oct; 62(10):1573-4. PubMed ID: 361228
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II evaluation of piperazinedione in metastatic breast carcinoma.
    Palmer RL; Samal BA; Vaughn CB; Tranum BL
    Cancer Treat Rep; 1977 Dec; 61(9):1711-2. PubMed ID: 340035
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
    Earhart RH; Khandekar JD; Faraggi D; Schinella RA; Davis TE
    Invest New Drugs; 1989 Jul; 7(2-3):255-60. PubMed ID: 2793383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
    Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
    Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of pyrazofurin in patients with carcinoma of the lung.
    Gralla RJ; Currie VE; Wittes RE; Golbey RB; Young CW
    Cancer Treat Rep; 1978 Mar; 62(3):451-2. PubMed ID: 348315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.